Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.

Renard J, Szkudlarek HJ, Kramar CP, Jobson CEL, Moura K, Rushlow WJ, Laviolette SR.

Sci Rep. 2017 Sep 12;7(1):11420. doi: 10.1038/s41598-017-11645-8.

2.

Coevolution in the timing of GABAergic and pyramidal neuron maturation in primates.

Charvet CJ, Šimić G, Kostović I, Knezović V, Vukšić M, Babić Leko M, Takahashi E, Sherwood CC, Wolfe MD, Finlay BL.

Proc Biol Sci. 2017 Aug 30;284(1861). pii: 20171169. doi: 10.1098/rspb.2017.1169.

PMID:
28855363
3.

GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies.

de Jonge JC, Vinkers CH, Hulshoff Pol HE, Marsman A.

Front Psychiatry. 2017 Aug 11;8:118. doi: 10.3389/fpsyt.2017.00118. eCollection 2017. Review.

4.

Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits.

Batista-Brito R, Vinck M, Ferguson KA, Chang JT, Laubender D, Lur G, Mossner JM, Hernandez VG, Ramakrishnan C, Deisseroth K, Higley MJ, Cardin JA.

Neuron. 2017 Aug 16;95(4):884-895.e9. doi: 10.1016/j.neuron.2017.07.034.

PMID:
28817803
5.

RNA-seq analysis of amygdala tissue reveals characteristic expression profiles in schizophrenia.

Chang X, Liu Y, Hahn CG, Gur RE, Sleiman PMA, Hakonarson H.

Transl Psychiatry. 2017 Aug 15;7(8):e1203. doi: 10.1038/tp.2017.154.

6.

NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: A newly identified correlation and its effects in schizophrenia.

Alherz F, Alherz M, Almusawi H.

Schizophr Res Cogn. 2017 Mar 9;8:1-6. doi: 10.1016/j.scog.2017.02.001. eCollection 2017 Jun. Review.

7.

Quantitative assessment of fibroblast growth factor receptor 1 expression in neurons and glia.

Choubey L, Collette JC, Smith KM.

PeerJ. 2017 Apr 18;5:e3173. doi: 10.7717/peerj.3173. eCollection 2017.

8.

Theranostic Biomarkers for Schizophrenia.

Perkovic MN, Erjavec GN, Strac DS, Uzun S, Kozumplik O, Pivac N.

Int J Mol Sci. 2017 Mar 30;18(4). pii: E733. doi: 10.3390/ijms18040733. Review.

9.

A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.

Kim YK, Choi J, Park SC.

Int J Mol Sci. 2017 Mar 30;18(4). pii: E734. doi: 10.3390/ijms18040734. Review.

10.

Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.

Larimore J, Zlatic SA, Arnold M, Singleton KS, Cross R, Rudolph H, Bruegge MV, Sweetman A, Garza C, Whisnant E, Faundez V.

Front Genet. 2017 Mar 10;8:28. doi: 10.3389/fgene.2017.00028. eCollection 2017.

11.

Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia.

Rocco BR, DeDionisio AM, Lewis DA, Fish KN.

Biol Psychiatry. 2017 Jul 1;82(1):40-48. doi: 10.1016/j.biopsych.2016.09.018. Epub 2016 Sep 29.

PMID:
27884423
12.
13.

Neural substrates underlying delusions in schizophrenia.

Zhu J, Zhuo C, Liu F, Xu L, Yu C.

Sci Rep. 2016 Sep 21;6:33857. doi: 10.1038/srep33857.

14.

Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia.

Stedehouder J, Kushner SA.

Mol Psychiatry. 2017 Jan;22(1):4-12. doi: 10.1038/mp.2016.147. Epub 2016 Sep 20. Review.

15.
16.

Cell-based therapies for the treatment of schizophrenia.

Donegan JJ, Lodge DJ.

Brain Res. 2017 Jan 15;1655:262-269. doi: 10.1016/j.brainres.2016.08.010. Epub 2016 Aug 18. Review.

PMID:
27544423
17.

Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study.

Joshi D, Catts VS, Olaya JC, Shannon Weickert C.

NPJ Schizophr. 2015 Mar 4;1:14004. doi: 10.1038/npjschz.2014.4. eCollection 2015.

18.

Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms.

Pantazopoulos H, Wiseman JT, Markota M, Ehrenfeld L, Berretta S.

Biol Psychiatry. 2017 Mar 15;81(6):536-547. doi: 10.1016/j.biopsych.2016.04.006. Epub 2016 Apr 16.

PMID:
27259817
19.

Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia.

Alshammari TK, Alshammari MA, Nenov MN, Hoxha E, Cambiaghi M, Marcinno A, James TF, Singh P, Labate D, Li J, Meltzer HY, Sacchetti B, Tempia F, Laezza F.

Transl Psychiatry. 2016 May 10;6:e806. doi: 10.1038/tp.2016.66.

20.

A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Malt EA, Juhasz K, Malt UF, Naumann T.

Front Behav Neurosci. 2016 Mar 30;10:59. doi: 10.3389/fnbeh.2016.00059. eCollection 2016.

Supplemental Content

Support Center